#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Paul Wright Email
VP CMC . Imugene Limited
Sydney,
LocationPrimary Email
How to contact Paul Wright
Join and see Paul's contact info for free!Current Roles
Employees:
92Revenue:
$14.3MAbout
Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies. Our product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies. We are supported by a leading team of international cancer experts with extensive experience in developing new cancer therapies with many approved for sale and marketing for global markets. ASX: IMUImugene Limited Address
Suite 1, 1233 High StSydney, null
AUS